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Conﬂicting arguments and results exist regarding the occurrence and phenotype of programmed cell death (PCD) in the malaria
parasite Plasmodium falciparum. Inconsistencies relate mainly to the number and type of PCD markers assessed and the diﬀerent
methodologies used in the studies. In this paper, we provide a comprehensive overview of the current state of knowledge and
empirical evidence for PCD in the intraerythrocytic stages of P. falciparum. We consider possible reasons for discrepancies in
the data and oﬀer suggestions towards more standardised investigation methods in this ﬁeld. Furthermore, we present genomic
evidenceforPCDmachineryinP.falciparum.WediscussthepotentialadaptiveornonadaptiveroleofPCDintheparasitelifecycle
and its possible exploitation in the development of novel drug targets. Lastly, we pose pertinent unanswered questions concerning
the PCD phenomenon in P. falciparum to provide future direction.
1.Introduction
Programmed cell death (PCD) forms an integral physio-
logical part of multicellular organisms, where it plays an
essential role in normal development and maintenance of
integrity and homeostasis. In addition, it forms part of the
defense response to combat infectious pathogens as well
as being involved in the pathogenesis of certain human
diseases (reviewed in [1–3]). This self-sacriﬁcial cell-death
phenomenon has also been demonstrated in unicellular
organisms, including parasitic protozoa (reviewed in [4,
5]). Apart from the ability to orchestrate their own death,
parasites can facilitate their development and survival by
inducing PCD in host cells (reviewed in [6]). These host-
pathogen interactions are complex, and the role of PCD
in balancing pathogenic and survival mechanisms remains
poorly understood.
The deﬁnitions of PCD and its various phenotypes are
considered in Table 2 of Appendix A.O b s e r v a t i o n so fP C D
have their foundations in the middle-late nineteenth century
as an awareness of physiological cell death [7, 8] although
the term was ﬁrst coined in 1964 by Lockshin and Williams
[9]. Apoptosis, now recognised as a prominent phenotype
of PCD, was described in 1972 by Kerr and coworkers [10].
More than 20 years later, apoptosis was demonstrated in a
unicellular trypanosome [11], and in 1997, it was described
in two species of malaria parasites, Plasmodium falciparum
[12]a n dP. yoelii [13]. Diﬀerent phenotypes of PCD have
been shown in evolutionary diverse unicellular eukaryote
lineages [14, 15]a sw e l la si np r o k a r y o t e s[ 16]. However,
a growing body of conﬂicting evidence regarding PCD in
Plasmodium has followed. We present a critical review of
current knowledge of this phenomenon, focusing on the
asexual intraerythrocytic stage of P. falciparum,a n do ﬀer
possible explanations for discrepancies in the data. We also
highlight some of the unanswered questions in this ﬁeld,
including the possible adaptive value of PCD, and allude to
the possible exploitation of this process in the identiﬁcation
of novel drug targets.2 Journal of Tropical Medicine
2. Evidence of PCD in Plasmodium falciparum
The appearance of “crisis form” morphology, ﬁrst described
in P. brasilianum in 1944 [17], has been widely observed in
P. falciparum and correlated with retardation of growth and
development, loss of synchronicity, and decline in parasite
numbers [18–22]. This morphological phenomenon was
linked to PCD by Picot et al. [12]. Many studies have
since cited the appearance of “crisis forms” as evidence
of PCD [12, 23–27]. However, the deﬁnition of “crisis
forms” is not entirely clear, often being simply described as
degenerateorabnormalparasites,makingitaparameterthat
is diﬃcult to objectively observe and quantify. In addition,
we and others have also observed the appearance of such
degenerate parasites in untreated in vitro cultures ([12, 23],
Engelbrecht et al., unpublished). Striving towards a uniﬁed
description of cell death phenotypes, it has been suggested
that morphological descriptions be replaced by functional
and/or biochemical criteria [28].
Several PCD markers of an apoptosis-like phenotype
have been documented in the ookinetes and zygotes of P.
berghei, both in vivo in the Anopheles mosquito as well as
in in vitro cultures, without external experimental stimuli
[29–31] although Le Chat and colleagues found very little
evidence to support this view [32]. Recently, it was shown
that ookinetes of P. falciparum exhibited evidence of an
apoptosis-like cell death in the midgut of the mosquito [33].
In the pathogenic asexual human blood stages of P.
falciparum, the biochemical evidence for PCD and especially
the phenotype of cell death remains highly controversial.
Some studies support the occurrence of PCD as apoptosis
[12, 26, 27, 34–36], while others suggest that the phenotype
more closely resembles autophagic cell death [37] or necrosis
[38]. Some overlap of apoptosis and autophagy has also
been noted [24], while other authors simply describe the
cell-death phenotype as nonapoptotic [25, 39]. At this
stage, it cannot be conclusively conﬁrmed whether any
PCD phenotype is typical and whether its manifestation is
essential and/or beneﬁcial to the parasite. Resolution of these
issues is an essential ﬁrst step in elucidating the underlying
PCD pathways in P. falciparum and their eﬀect on host-
pathogen interactions. A better understanding of both the
proximate (“how”) and the ultimate (“why”) reasons of such
a mechanism will impact on our knowledge of PCD in
unicellular parasites and may provide clues for prospective
drug targets.
As u m m a r yo fs t u d i e so nP C Dm a r k e r si nP. falciparum
is presented in Table 1. On face value, the conﬂicting data
oﬀered by these studies seem daunting when attempting to
reach a conclusion on PCD in P. falciparum. Consideration
is thus given to possible explanations for the discrepancies
that may lessen the controversy, and thereby either answer
pertinent questions or raise new issues about the cell-death
mechanismsofP.falciparum.Thisconsiderationisaddressed
in two parts. First, by considering confounding variables
of the system, such as diﬀerences in the strain, stimulus,
or life stage studied. Second, methodological pitfalls that
may distort the interpretation of results are examined. By
evaluating conﬂicting evidence as individual pieces of the
same puzzle, rather than diﬀerent pieces for the same open
space, a larger and more descriptive picture forms.
3. Conﬂict due to Confounding Variables:
Is There Method in the Madness?
3.1. P. Falciparum Strains. Numerous strains of P. falciparum
have been used to study PCD, including chloroquine-
resistant strains such as 7G8, FCR3, Lili, K1, PSS1, and Dd2,
as well as strains that are sensitive to the drug, for example,
3D7 and F32 (Table 1). This complicates interpretation of
the results when chloroquine (8 out of 12 studies) and other
drugs are used to induce cell death, especially since it has
been speculated that the development of chloroquine drug
resistance may be correlated with a decreased susceptibility
to undergo PCD [26]. Recently, reduced sensitivity to
artemisinin has been described [40], but gene expression
studies have not linked this phenotype to changes in PCD
[41]. Diﬀerent strains seem to diﬀer in their susceptibility
to undergo PCD and manifest diﬀerent phenotypes. The
3D7 strain appears to be most susceptible to PCD with an
apoptotic phenotype resulting from exposure of parasite cul-
tures to chloroquine [12, 26, 34] etoposide [26], or increased
temperatures [27]. Apoptosis has also been reported in the
Dd2 strain under high in vitro parasite densities [36]. Other
strainsmanifestentirelydiﬀerentcelldeathphenotypes,such
as the PSS1 strain that showed evidence of autophagic cell
death, as indicated by cytoplasmic vacuolisation without
chromatin condensation or DNA fragmentation and caspase
involvement [37]. The CSC-1 strain lacked markers of
apoptosis and instead showed swelling and food vacuole
lysis, resulting in secondary necrosis after stimulation with
drugs or febrile temperatures [38]. Drug-induced cell death
of the F32 strain did not exhibit any of the typical markers
of apoptosis although the occurrence of PCD was not ruled
out [25]. Conﬂicting results exist for the 7G8 strain, where
chloroquine either induced apoptosis [26, 34] or caused cell
death showing features of both apoptosis and autophagy
[24].StudiesutilisingmultipleP.falciparumstrainssubjected
to the same stimuli within the same laboratory provide
the best evidence to show interstrain diﬀerences in PCD
phenotypes and susceptibilities [12, 26, 34].
3.2. Cell-Death Stimulus. Widely diﬀering stimuli (Table 1),
concentrations, and exposure times have been used to study
PCD in P. falciparum, which makes direct comparisons
problematic.Antimalariadrugsarethemostcommonlyused
experimental trigger, but results have not been consistent.
Treatment of cultures for 6 and 24 hours with 40nM
chloroquine (corresponding to the IC50 value of the drug)
revealed DNA fragmentation suggestive of apoptosis [12].
However, another study using the same strain and stimulus
showed almost no response at a comparable chloroquine
concentration of 30nM, with a signiﬁcant eﬀect only evident
above 30μM chloroquine treatment for 8 or 10 hours [34].
Apart from this dose-dependent eﬀect of a single drug, the
mode of action of a drug also impacts signiﬁcantly on the
type of cell death. Nyakeriga and coworkers treated the F32Journal of Tropical Medicine 3
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Figure 1: DNA fragmentation as illustrated by the TUNEL assay and agarose gel electrophoresis. Plot regions are denoted as nonfragmented
(NF) and fragmented (FR). (a) TUNEL results showing parasites at 5.0% parasitaemia (blue) and parasites at parasitaemia of 7.2%, which
failed to progress beyond the ring stage (green), after a decline from a high parasitaemia of >11%. (b) TUNEL results of untreated parasites
(blue) and parasites treated with DNase 1 (red). (c) Agarose gel electrophoresis of genomic DNA from intact untreated (left) and DNase
1-treated (right) parasites showing a smear of DNA fragments.
P. falciparum strain with several drugs with diﬀerent modes
ofactionanddemonstratedthattheeﬀectonnumerousPCD
markers varied signiﬁcantly [25].
A question arises as to whether antimalaria drugs are an
appropriate stimulus, since the reaction of the parasite to the
drug may be diﬀerent in the in vitro system compared to the
in vivo disease. In PCD experiments, the dose of the drug
is adjusted so that the death rate is less than 100%, which
correlates with the concept of PCD, where some parasites
die to beneﬁt the rest of the population although it may also
reﬂect the fact that not all parasites have taken up the drug.
However, in vivo, when a patient with malaria is treated, the
drugs rapidly and eﬀectively kill all parasites, implying that
at least in some parasites, death is an uncontrolled event as
opposed to a preprogrammed mechanism. Physiologically
relevant triggers may therefore better reﬂect the pathways
that operate in vivo.
During the intraerythrocytic cycle of development, P.
falciparum i se x p o s e dt ot e m p e r a t u r e su pt o4 1 ◦C during
periodic bouts of fever in the human host, which occur
in response to erythrocyte rupture and release of new
merozoites. Incubation of parasites at febrile temperatures
h a sb e e nu s e da san a t u r a ls t i m u l u st os t u d yP C Db u tw i t h
conﬂicting results. One study showed DNA fragmentation
after 2 hours at 41◦C[ 27], whereas a similar study demon-
strated no eﬀect after incubation at 40◦C for as long as 16
hours [38], albeit with diﬀerent strains (3D7 and CSC-1,
resp.).
The self-limiting eﬀect of increasing population densities
has also been investigated as a stressor for triggering PCD
[36]. The Dd2 strain showed growth stagnation at <6%
parasitaemia in highly synchronous cultures, with apoptotic
markers including mild DNA fragmentation as measured
by the TUNEL assay [36]. This contrasts with our studies
on the 3D7 strain, which reached peak parasitaemia levels
of >11% and following decline, exhibited very high levels
of DNA fragmentation, also measured by the TUNEL assay
(Figure 1(a)). These parasites remained in the ring stage
of the life cycle and failed to progress to trophozoites and
schizonts.
3.3. Life Cycle Stages and Culture Conditions. P. falciparum
has a complex life cycle and is subjected to very diﬀerent
environmental conditions as it shuttles between its human
and mosquito hosts. Evidence relating to PCD of the
ookinetestageinthemosquitomidgutwasbrieﬂymentioned
earlier. Subsequent to invasion of human erythrocytes, the
parasite develops through sequential stages of proliferation,
whichresponddiﬀerentlytoexternalstimulithatmaytrigger
PCD.Thishampersthegenerationofconsistentresults,since
researchers have used either asynchronous cultures or else
diﬀerent stages of synchronous cultures (rings, trophozoites,
or schizonts). In addition, there is wide variation in initial
parasitaemia and haematocrit as well as the composition of
the culture medium (e.g., the use of human plasma or serum
or diﬀerent concentrations of Albumax).
Anothervariableininvitrocultureexperimentsrelatesto
thepresenceofresidualwhitebloodcells(leukocytes)despite
wash steps to purify erythrocytes. These cells may undergo
PCD in response to the stimulus applied to induce parasite
death, and since they contain DNA, this may interfere with4 Journal of Tropical Medicine
studies of DNA fragmentation. This dilemma was illustrated
by Porter et al. [38], who demonstrated oligonucleosomal
DNA laddering by agarose gel electrophoresis in parasitised
erythrocyte cultures treated with chloroquine, similar to that
r e p o r t e db yP i c o te ta l .[ 12]. However, the laddering pattern
w a sa b s e n to n c ec u l t u r e sh a db e e nd e p l e t e do fl e u k o c y t e s
by aﬃnity chromatography. Moreover, treatment of whole
bloodwithchloroquineproducedasimilarladderingpattern
[38]. Cognisance should therefore be taken of possible
false positive results when interpreting DNA laddering or
fragmentation experiments.
Finally, each stage of development is associated with
ad i ﬀerent repertoire of mRNA and proteins, which also
confounds the issue and may oﬀer another explanation of
discrepancies in results, since the appropriate executors of
PCD may not be present in the experimental stage under
investigation.
4. Conﬂict due to Methodological Choice or
Design:MadnessintheMethods?
Apart from discrepancies in data due to diﬀerences in
the studied system, as described above, it is also possible
that problems may be encountered in the methods used
to study the system. Morphological markers are unreliable
although the cellular and molecular methods that have
been recommended to replace them [28] are currently
also not perfect and suﬀer from diverse drawbacks [42].
Technological approaches to detect markers of PCD in
protozoanparasitesareborrowedfromstudiesinmetazoans,
and commercial kits have typically been optimised for
mammalian systems. They may therefore not be appropriate
for studies in Plasmodium. Some of the most common
markers of PCD, especially apoptosis, that have been used
in P. falciparum are DNA fragmentation, alterations in the
mitochondrial and plasma membranes and the involvement
of proteases. Some of the methodological pitfalls associated
with these techniques are considered below.
4.1. DNA Fragmentation: Agarose Gel Electrophoresis versus
TUNEL Assay. Oligonucleosomal DNA fragmentation is
considered one of the hallmarks of the late stages of
apoptosis, resulting from internucleosomal DNA cleavage,
which produces a characteristic ladder of DNA fragments
(see Table 2 in Appendix A)[ 2, 28]. Two methods of
detection are used in P. falciparum studies: (1) agarose gel
electrophoresis involving the electrophoretic resolution and
visualisation of isolated DNA by ethidium bromide or SYBR
green staining, or more commonly (2) the TUNEL (Termi-
nal deoxynucleotidyltransferase-mediated dUTP Nick End
Labelling) assay, which relies on enzyme (TdT)-mediated
integration of a ﬂuorochrome-conjugated base (dUTP) to
free 3 -OH ends of fragmented DNA strands in whole cells,
d et ect edb yﬂo wcyt o metry ,ﬂ uo r esc e nc emicr osc o p y ,o rlight
microscopy with appropriate ﬁlters [2, 43]. Table 1 provides
an overview of the DNA fragmentation results obtained
in various P. falciparum PCD studies. These results are
occasionally in conﬂict with other detected markers of PCD
in the same study. This may be due to the choice or execution
of the detection method, as considered below.
The initial suggestion of PCD in P. falciparum was based
on oligonucleosomal DNA fragmentation demonstrated by
a ladder of DNA fragments resolved on agarose gels. The
low sensitivity of conventional ethidium bromide staining
necessitated radiolabelling of free DNA ends prior to elec-
trophoresis and Southern blotting [12]. Our own data attest
to the problem of low sensitivity: despite signiﬁcant growth
inhibition and the prominent appearance of crisis forms
in chloroquine- and heat-treated 3D7 parasites, we have
been unable to demonstrate the expected oligonucleosomal
laddering pattern on agarose gels (1-2μg DNA loaded)
(Engelbrecht et al., unpublished data). This contrasts with
the ﬁndings of Ch’ng and colleagues who demonstrated
DNA fragmentation by the TUNEL assay at compara-
ble concentrations of chloroquine, using the same strain
[34].
The TUNEL assay analysed by ﬂow cytometry appears
to be accepted as the standard for detecting DNA frag-
mentation in P. falciparum. However, the major drawback
of this method is that it cannot distinguish the type of
DNA fragmentation, and therefore, oligonucleosomal DNA
fragments, as well as random fragments, will yield positive
results. No deﬁnite conclusion on the type of PCD can
thus be reached, since fragmented DNA with liberated 3 -
OH ends may be generated in cells undergoing apoptosis,
necrosis, or autophagy [43–46]. Our own results conﬁrmed
this shortcoming: insituDNA digestion in P.falciparumwith
DNase 1, which is utilised in several studies as a positive
control [25–27, 36, 37], showed ∼90% TUNEL positive
parasites (Figure 1(b)) although this treatment manifested
as a homogenous smear of DNA (that could be associated
withnecrosis)onagarosegelsstainedwithethidiumbromide
(Figure 1(c)). A careful choice of controls for both apoptosis
and necrosis is thus essential for correct interpretation of
DNA fragmentation results. Perhaps exploitation of the
ability of ﬂow cytometry to measure several parameters
simultaneously in individual cells may also provide the
opportunity to include additional markers to discriminate
between DNA fragmentation in apoptotic and necrotic
cells.
Furthermore, analysis of the TUNEL assay by ﬂuores-
cence microscopy [26, 27] is only semiquantitative and may
not provide an accurate representation of the portion of the
parasite population manifesting DNA fragmentation. These
results should therefore be corroborated by quantitative
ﬂow cytometry. Totino et al. [37], observed <10% of
TUNEL positive parasites using ﬂow cytometry, despite
signiﬁcant (∼40%–75%) parasite death, after treatment with
staurosporine (an inducer of apoptosis), or SNAP (a nitric
oxide donor) or the antimalaria drug, chloroquine. The
authors thus suggested that TUNEL positive fragmentation,
detected solely by ﬂuorescence microscopy [26], may only
represent a small fraction of the population [37], and since a
small percentage of TUNEL positive parasites have also been
observed in untreated cultures [34, 37], these results should
be interpreted with caution. It should be noted, however,
that Totino and coworkers assessed parasite viability withJournal of Tropical Medicine 5
rhodamine staining, which correlates with an early apoptotic
loss of mitochondrial membrane potential, whereas DNA
degradation is a later event, and this may partly explain the
lack of correlation between DNA fragmentation and parasite
death [37].
With each method exhibiting its own drawbacks, one
may ask which one, if any, of the above should be used
to detect DNA fragmentation? Agarose gel electrophoresis
is simple and economical to perform and provides con-
clusive evidence for the type of DNA fragmentation but
suﬀers from low sensitivity and is only semiquantitative.
The low sensitivity may be overcome by substantial, time-
consuming modiﬁcations, such as Southern blot analysis
[12]. The TUNEL assay, in contrast, is highly sensitive, rapid,
and quantitative if assessed by ﬂow cytometry. However,
it cannot discriminate between speciﬁc oligonucleosomal
cleavage of DNA and random degradation, which is essential
in determining the type of cell death. It would thus be
prudent to verify the type of DNA fragmentation with
agarose gels for those samples that produce positive TUNEL
results.
4.2. Loss of Mitochondrial Transmembrane Potential (Δψm).
MitochondriaplayakeyroleinPCD,andalossofmembrane
potential (Δψm) usually precedes complete permeabilisation
of the mitochondrial membrane [28, 47], which triggers
downstream events in the PCD cascade. In apoptosis,
loss of Δψm is an early event occurring prior to other
apoptotic manifestations such as chromatin condensation,
DNA laddering, or phosphatidylserine (PS) externalisation
[47]. However, decreased Δψm and mitochondrial mem-
brane permeabilisation may also occur during early necrosis
[28, 47, 48] prior to the appearance of vacuolisation and
cytoplasmic swelling [47].
The mitochondrial membrane potential is normally
evaluatedwithlipophiliccationicprobes[47],suchasDiOC6
[24,25,38],JC-1[26,34,35],TMRE(tetramethylrhodamine
ethyl ester) [36], or rhodamine 123 [37]. The ﬂuorescent
probesaredetectedeitherbyspectroﬂuorimetry,ﬂowcytom-
etry, or ﬂuorescence microscopy. As summarised in Table 1,
ad e c r e a s ei nΔψm was observed after cell death had been
induced in various strains with drugs or heat or bilirubin,
but due to the nonspeciﬁcity of this parameter, it was
not always correlated with apoptosis. Conﬂicting results
were obtained by Nyakeriga and colleagues, who could not
detect any loss of Δψm after treatment of the chloroquine-
sensitive F32 strain with chloroquine or etoposide, a
topoisomerase II inhibitor [25]. As expected, atovaquone,
which targets the mitochondria, decreased the Δψm [25].
The choice of mitochondrial probe may have a signiﬁcant
inﬂuence on results, as probes diﬀer in both their speciﬁc
and nonspeciﬁc binding targets and are often mitochondrial
inhibitors themselves [49, 50] .V a r i o u sp r o b e sh a v ea l s o
shown diﬀerent responses depending on the stimulus used
to induce mitochondrial dysregulation, albeit in a human
cell line [50]. It is also crucial to ensure proper staining
of the parasites and to include appropriate experimental
controls. In addition to an untreated parasite culture and a
nonparasitised erythrocyte control to monitor nonspeciﬁc
binding, it is important to include a positive control, such
as a mitochondrial uncoupling agent (CCCP), to ensure
the validity of the results. Furthermore, the mitochondrial
localisation of the dye should be veriﬁed with ﬂuorescence
microscopy. In view of the ambiguous nature of this marker,
it cannot be used in isolation to determine the phenotype of
PCD.
4.3. Phosphatidylserine (PS) Externalisation. Viable erythro-
cytes normally maintain an asymmetrical transbilayer distri-
bution of phospholipids, with the anionic aminophospho-
lipid phosphatidylserine (PS) localised almost exclusively on
the inner leaﬂet of the plasma membrane [51]. In a number
of conditions, such as sickle cell anaemia and thalassaemia as
well as senescent erythrocytes, the asymmetry of the plasma
membraneislost,leadingtoexternalisationofPStotheouter
leaﬂet [51].
During apoptosis, complete mitochondrial membrane
permeabilisation in response to a PCD stimulus results in
the release of cytochrome c and calcium, which triggers the
translocation of PS [28, 52]. This early PS externalization
is a widely used marker of apoptosis in mammalian cells
and has also been used in unicellular lineages [42]. In
mammalian cells, the externalised PS is thought to serve as
a signal to phagocytes to engulf and digest apoptotic cellular
remnants, thereby preventing an immune response although
the phenomenon has yet to be fully explained or exclusively
linked to apoptosis [2, 53]. This ﬂip-ﬂop of PS is commonly
detectedwithﬂuorochrome-labelledAnnexinV,whichbinds
to PS with high aﬃnity although it may also bind to other
anionic phospholipids [53]. The assay usually includes a
membrane-impermeable vital dye such as propidium iodide
to exclude demised cells that have become permeable.
In Plasmodium, PS externalization has been detected
during apoptosis of the extracellular ookinetes and zygotes
of P. berghei [29, 30, 33]. However, detection of PS exposure
in the intracellular erythrocytic stages is complicated by the
presence of several membranes. Apart from the erythrocyte
membrane, the parasite has a plasma membrane and is sur-
rounded by a parasitophorous vacuolar membrane (PVM).
The host cell membrane may be removed by extensive
aﬃnity puriﬁcation steps and selective lysis of the PVM
may be achieved with increasing concentrations of saponin
or sorbitol [23, 54] although the purity of the parasite
plasma membrane would have to be veriﬁed. The functional
relevance of potential PS translocation to the outer surface of
one of the parasite membranes is not clear, since the parasite
is still within the intracellular milieu of the erythrocyte.
However, P. falciparum remodels the host erythrocyte mem-
brane extensively during its intracellular development, and
although it initially prevents PS externalization to protect
the infected host cell from clearance by macrophages, PS
exposure becomes apparent during the schizont stage [6,
55, 56]. It is not known whether this change is speciﬁcally
induced by a parasite undergoing PCD, but phagocytosis
of the dead parasite will limit the immune response and
production of inﬂammatory cytokines, which represents a
survival advantage for the parasite. An investigation of the
exposure of PS on the outer erythrocyte membrane surface6 Journal of Tropical Medicine
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Figure 2: Phosphatidylserine externalisation (PS+) measured by FITC-Annexin V binding in both infected erythrocytes (iRBC) and
their neighbouring noninfected erythrocytes (nRBC). iRBC were identiﬁed by the uptake of the cell-permeable DNA-binding dye
dihydroethidium. An increase in PS externalisation can be seen by comparing an uninfected erythrocyte culture (a), to a parasite culture (b),
both maintained at 37◦C, and a heat-stressed parasite culture maintained at 40◦C for 48 hours (c).
after stimulating PCD in P. falciparum and a comparison
to PS levels in untreated infected cells (Figure 2) should be
correlated with other markers of PCD in the parasite.
4.4. Cysteine Protease Involvement. Apoptosis is a genetically
regulated catabolic process, which is executed by a prote-
olytic cascade of cysteine proteases, known as caspases [28].
Thus far, no true caspases have been identiﬁed in Plasmod-
ium [23] although plant-like metacaspases have been found
[57]. Nevertheless, the activation of caspase-like enzymes
during PCD has often been used as a marker for apoptosis
as summarised in Table 1.
Detection of caspase-like activity in P. falciparum relies
on the use of ﬂuorochrome-conjugated substrates or in-
hibitors which emit a ﬂuorescent signal after proteolytic
cleavage of the peptide substrate (such as VAD or DEVD)
or irreversible binding of the inhibitor to the enzyme. In
addition, substrate analogues linked to ﬂuoromethyl ketoneJournal of Tropical Medicine 7
have also been used as inhibitors. The emitted ﬂuorescence
is quantiﬁed by ﬂow cytometry or spectroﬂuorimetry and/or
visualization by ﬂuorescence microscopy.
Increased caspase-like activity was demonstrated in res-
ponse to chloroquine [34], staurosporine [34], and bilirubin
[35]. However, other groups found no evidence of cysteine
protease involvement after treatment with various drugs [37,
38]o rh e a t[ 38]. During chloroquine-induced PCD, Ch’ng
andcoworkersusedanarrayofinhibitorsandconcludedthat
clan CA cysteine proteases such as cathepsins and calpains
mediated parasite death [34]. This is in contrast to studies
implicating clan CD proteases (metacaspases) in response
to chloroquine treatment [26] or caspase 3-like enzymes
following bilirubin exposure [35].
These conﬂicting results highlight several important ca-
veats. (1) Commercial kits and reagents have primarily
been developed for mammalian systems, and Plasmodium
enzymes may exhibit diﬀerent substrate speciﬁcity. (2)
Broad spectrum caspase inhibitors also inhibit other cysteine
proteases [58], and oﬀ-target eﬀects may also complicate the
interpretation of results [59]. (3) The enzymes implicated
by substrate and/or inhibitor assays in P. falciparum have
not been characterised and conclusively linked to parasite
apoptosis. (4) Caspase-independent apoptosis has also been
described [60–62], and this may occur when proteases have
been inhibited. Thus, the inhibitors may not prevent cell
demise but simply shift the phenotype of cell death to one
that is not dependent on the aﬀected protease [63].
5. Is There a Curefor the Madness?
The bulk of the evidence presented in this paper favors
the occurrence of some form of PCD in P. falciparum;
however, the major debate centres around the phenotype.
The current classiﬁcation of distinct cell death phenotypes
[28] is important, since a uniform nomenclature provides
clarity to the ﬁeld; however, it may also exacerbate the
problem,sinceitisbecomingevidentthatparasitedeathmay
in some instances display features and markers of more than
one phenotype or possibly early and late characteristics of
a single phenotype. This may relate to diﬀerent subsets of
parasites in the study population responding in a slightly
diﬀerent way to the death stimulus or initiating PCD at
slightly diﬀerent time intervals if cultures are not tightly
synchronised, since some stagesmay be moresusceptible to a
speciﬁc trigger. The NCCD has recognised this dilemma and
proposes that the move away from morphological features to
biochemical characteristics may alleviate the situation [28].
To facilitate interstudy comparison and consistency, an
integrated strategy whereby researchers evaluate as many
appropriate markers as possible using standardised methods
and culture conditions in a single study may be beneﬁcial to
resolve the current inconsistencies in the data. In addition,
a more rigorous experimental approach will increase the
conﬁdence in the data. Appropriate controls are therefore
essential,andanadequatenumberoftechnicalandbiological
replicates should be assessed to ensure a reliable and consis-
tent outcome.
6. GenomicEvidence of PCD inPlasmodium
Plasmodium lacks true caspases [23, 64, 65]b u tg e n o m i c
evidence for metacaspases (see Table 3 in Appendix B)h a s
been found in P. falciparum [23, 26, 32, 57, 66, 67], P. berghei
[32], and P. vivax [32, 66]a sw e l la sP. knowlesi and P. yoelii
[66].
These metacaspases belong to the C14 family of clan CD
cysteine proteases. PfMC1 (PF13 0289) has been partly char-
acterised using computational methods [26] and contains
an N-terminal caspase recruitment domain (CARD) and a
C-terminal catalytic domain including the histidine-cysteine
dyad essential for activity. P. berghei parasites have been
genetically manipulated to produce a knockout clone lacking
the orthologous PbMC1 (PB001074) gene in an attempt to
evaluate the role of the enzyme in apoptosis of sexual stage
parasites [32]. A comparison of wild-type and knockout
parasites has produced conﬂicting results. The gene either
seems to be functionally redundant, since it had no eﬀect on
apoptotic markers [32] (unpublished data cited in [42]), or
it appeared to modulate ookinete numbers [68].
Transcription data revealed that PbMC1 is actively ex-
pressed in all mosquito stages of P. berghei and in female
gametocytes but not in the asexual erythrocytic stages of
development. PfMC1 is transcribed in the blood stages of
P. falciparum. However, transcription does not guarantee
active expression of the protein, and thus, the involvement
of metacaspases in cell death processes is still unresolved.
A P. falciparum gene (PF10450c) coding for a putative
apoptosis-related protein showed increased mRNA expres-
sion in parasites exposed to bilirubin, and this correlated
with several other markers of apoptosis [35].
Genomic evidence [66] for the existence of elements
of a PCD pathway in P. falciparum is presented in
Table 3 of Appendix B. These genes encode proteins that
are involved in all stages of PCD, including induction,
regulation, and execution, and although it remains to be
proven experimentally, these ﬁndings suggest that a classical
PCD pathway exists in Plasmodium. However, the possibil-
ity that these proteins/domains have unrelated pleiotropic
functions cannot be excluded. The identiﬁcation of amino
acid sequences with structural similarity to p53 DNA-
binding domains in P. falciparum is a particularly exciting
ﬁnding. The low sequence similarity between Plasmodium
and known p53 DBDs and the evidence for p53-like activity
in plants and green algae [69, 70] raise the intriguing
possibilitythatp53-dependantapoptosisisextremelyancient
or arose more than once in eukaryote evolution.
7.What Is the Role ofPCD inP. falciparum?
Despite conﬂicting evidence presented in the previous sec-
tions, it seems clear that markers of PCD can be detected in
P. falciparum in response to numerous stimuli. This raises
the question of the relevance of this phenomenon in a
protozoan parasite. Although the adaptive advantage of PCD
is more easily understood in multicellular organisms, where
the sacriﬁce of some cells contributes to the development
and maintenance of the higher-level organisms [14], the idea8 Journal of Tropical Medicine
of suicide is diﬃcult to reconcile with unicellular parasites
(reviewed in [1, 14]). It is generally argued that PCD in
P. falciparum may have developed by group-level selection,
providing a survival beneﬁt to kin in a population of closely
related individuals [23]. In P. falciparum,P C Dm a yp r o v i d e
a number of beneﬁts, and one of the most widely suggested
is the self-limitation of the parasite’s burden on the host, to
facilitate transmission. However, it should not be assumed
that the existence of a PCD mechanism in P. falciparum is an
adaptive trait even if its execution provides a survival beneﬁt
to kin, population or species.
Empirical evidence for adaptive programmed death in
unicellular lineages has only been provided in two organisms
so far. In the yeast, S. cerevisiae, a genetically encoded
altruistic aging programme has been demonstrated [71, 72],
and in the green alga C. reinhardtii, the substances released
during PCD were shown to beneﬁt others, suggesting the
phenomenon is a group level adaptation in this organism
[73]. However, PCD may have evolved and been maintained
as a nonadaptive or pleiotropic trait in other organisms
and still be genetically regulated [14]. Furthermore, the
lessons learnt from other unicellular organisms, including
protozoan parasites, such as Trypanosomes or Toxoplasma,
may not always apply to P. falciparum, especially to the
highlyvirulentintraerythrocyticstages,whichareundervery
diﬀerent environmental constraints and pressure.
8.CanW eExp l o itPCDasaN o v elD rugT arg et?
If PCD is a group-level parasite survival mechanism, it
would have to be downregulated in a therapeutic context. In
addition, PCD in Plasmodium would have to be adaptive in
its nature in order for its manipulation by drug therapy to
come at a signiﬁcant survival cost to parasite populations.
To minimise harmful side eﬀects in patients, a protein
in the PCD pathway that is targeted should be suﬃciently
diﬀerent from the human counterpart. Metacaspases have
been implicated as PCD eﬀector molecules in P. falciparum,
and these enzymes are only found in protozoa. However,
treatment of mice with a pan-caspase inhibitor, z-VAD, did
not protect them from the lethal eﬀects of experimentally
inducedcerebralmalaria.Asimilarantiapoptotictherapeutic
approachusingtransgenicmicethatoverexpressedBcl-2also
failed [74].
An interesting aspect that has not been dealt with in this
paper is that Plasmodium induces apoptosis in numerous
human host cell types, such as endothelial, neuronal, and
retinal cells [6]. In contrast, infected hepatocytes and
erythrocytes are protected from apoptosis by the parasite to
ensure its own survival [55]. An antiapoptotic therapy that
uses erythropoietin as a neuroprotective adjuvant to prevent
neuronal apoptosis provides a new treatment option. It has
been successful in experimental murine cerebral malaria
[75], and a recent human study showed that African children
with high levels of erythropoietin were protected against
neurological sequelae of cerebral malaria [76].
Since malaria is an acute and aggressive infection that
requires immediate treatment with drugs that rapidly and
eﬀectively kill all parasites, the concept of treating patients
with agents that promote PCD may not have the required
eﬀect unless they are used in the context of an adjuvant.
However, future elucidation of PCD pathways may yield
potential target proteins that are multifunctional, which will
broaden the scope of the drug and interfere with more than
one aspect of the parasite’s biology.
9.Perspective
With the controversy surrounding PCD phenotypes in P.
falciparum being further complicated by methodological
diﬃculties in the detection of several PCD markers and the
often ambiguous nature of the markers themselves, a more
innovative approach may be required to successfully charac-
terise and exploit possible PCD pathways in P. falciparum.
Current thinking on PCD in P. falciparum i sb a s e do na
multicellular PCD paradigm, which may not be appropriate
for the unicellular malaria parasite, since it may diﬀer in its
ultimate and proximate reasons in reaching the same cellular
endpoint. However, with our current lack of knowledge of
PCD in P. falciparum, the metazoan template is a useful
frame of reference and provides a starting point to identify
homologous PCD genes and proteins in Plasmodium species.
The development of new and more powerful computational
algorithms to investigate the highly unusual P. falciparum
genome and proteome will help direct future investigations.
Theidentiﬁcationofkeygenesandbiochemicalcharacterisa-
tion of the recombinant P. falciparum proteins will facilitate
developmentofparasite-speciﬁcreagents,whichwillprovide
new tools and improve the speciﬁcity and sensitivity of
marker assays. Genomic evidence of PCD machinery also
paves the way for parasite gene manipulation and the
generation of selective knockout parasites, which can then be
used to assess the functional role of the gene in PCD.
Numerous challenges still exist for researchers in this
ﬁeld, and a few of these unanswered questions are delineated
in Appendix C. The current phase of research is mainly
descriptive, whereby markers of PCD are assessed and docu-
mented following in vitro exposure of P. falciparum cultures
to adverse conditions. This provides indirect evidence of
key participants in PCD, such as cysteine proteases although
there is still no clear molecular link between the markers and
the actual biochemical events in the parasite and the ﬁnal
phenotype. This should form the basis for the next exciting
phase of study and the challenge for researchers will be to
elucidate and clarify the phenotypic expression of PCD and
to identify and characterise the pathway(s) that underlie this
fundamental biological process in P. falciparum.
Appendices
A.CharacteristicsofProgrammedCellDeath
(PCD)Phenotypes(Table 2)
PCD may be deﬁned as any cell death process that results
from the activation of an intrinsic cell death programme;
that is, it is a genetically regulated sequential process. InJournal of Tropical Medicine 9
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Table 2
Cell death phenotype Morphology Common biochemical markers
Apoptosis
(i) Decreased cellular volume (pyknosis)
(ii) Rounding-up of cell (i) Loss of mitochondrial membrane potential (ΔΨm)
(iii) Intact plasma membrane blebbing (ii) Cysteine protease activation
(iv) Chromatin condensation (iii) Phosphatidylserine externalization
(v) Nuclear fragmentation (iv) Oligonucleosomal DNA fragmentation
(vi) Apoptotic body formation (v) Exclusion of cell-impermeable vital dyes in early
stages
(vii) Minor changes in cytoplasmic organelles (vi) Increase in reactive oxidants
Autophagy
(i) Cytoplasmic vacuolization (i) Starvation response
(ii) Autophagic vesicles with double membranes (ii) Induction of membrane rearrangement genes (e.g.
ATG1 and ATG8) to form autophagosomes
(iii) No chromatin condensation (iii) Caspase 8 involvement
Necrosis
(i) Increased cellular volume (oncosis) (i) Nonspeciﬁc DNA degradation
(ii) Loss of integrity and rupture of plasma
membrane (ii) Inclusion of cell-impermeable vital dyes
(iii) Swelling of cytoplasmic organelles (iii) Loss of ΔΨm
recognition of the recommendations of the Nomenclature
Committee on Cell Death (NCCD) in striving towards
uniform nomenclature [28], apoptosis, and autophagy are
considered phenotypes of PCD in Plasmodium. Apoptosis is
associatedwithhighlycharacteristiccellularandbiochemical
changes in response to detrimental external or internal
stimuli, resulting in cell death [2]. Autophagy represents the
sequestration of cellular material into autophagosomes for
subsequent degradation and typically promotes survival, but
under extreme or prolonged adverse conditions, the cell may
die [77]. Necrosis, once viewed as an entirely uncontrolled
manner of cell death, may also be a genetically regulated and
energy-dependent form of cell death [78]. However, necrosis
is a poorly deﬁned phenotype in Plasmodium and in the
absence of evidence for a regulated sequence of events it is
considered a non-PCD form of cell death in Plasmodium.
Each cell death phenotype is characterised by a distinctive
morphology; however, the NCCD has recommended that
morphological cell death deﬁnitions be replaced with more
objective functional or biochemical criteria. The main
morphological featuresof the diﬀerent cell death phenotypes
and some of the common markers for each are listed in
the table below. It should be noted that phenotypes may
not be exclusive and overlap may therefore occur between
the markers. Any marker in isolation should thus not be
considered proof of a particular PCD phenotype.
B. Genomic Elements of a PCD Pathway in
Four Plasmodium Genomes(Table 3)
Evidence has recently accumulated demonstrating the mani-
festationofoneormoremarkersofPCDintheasexualblood
stages of P. falciparum in response to various experimental
stimuli to induce parasite death. In the sexual developmental
stages within the mosquito host, features of apoptosis have
also been observed in P. berghei and P. falciparum.H o w e v e r ,
the presence of these markers does not necessarily imply the
existence of a complete pathway.
There is very little information concerning the genes
and proteins involved in PCD in Plasmodium.S o m eo f
the reasons for this lack of data relate to the fact that the
P. falciparum genome is a notoriously diﬃcult genome to
investigate. It is evolutionary distant from other taxa due
to fast-evolving genes and is phylogenetically ancient and
complex [79]; there are frequent low-complexity regions
and other inserts in genes, and the nucleotide and codon
biases render the methods for orthologue identiﬁcation less
sensitive and speciﬁc. Conventional homology methods have
therefore yielded limited results, which is evident from the
ﬁnding that ∼60% of predicted proteins in the P. falciparum
genome have no signiﬁcant homology to known proteins
[80].
In a recent study, six key proteins or domains were
selected based on their involvement in the four main stages
of the p53-dependent pathway: induction (ATM), initiation
(p53), regulation (MDM2, CR6 and IAP) and execution
(peptidase C14). Hidden Markov model (HMM) libraries
were constructed (supplementary ﬁle which is available
online at doi:10.1155/2012/646534, [66]) based on multiple
sequence alignments performed with MAFFT [81]a n d
edited with BioEdit [82]. Construction, calibration and
implementation of HMMs were conducted with HMMER
[83]. A detailed analysis of the four Plasmodium genomes
was performed using these HMM libraries, as well as
an array of computational approaches including standard
homology methods, phylogenetics, structural models and
a novel evolutionary rate-based alignment algorithm FIRE
(Functional Inference using the Rates of Evolution), which
was developed to identify homologous and analogous genes
in organisms with unusual genomes, such as P. falciparum,
and hence low sequence similarity [84]. Hits are listed in
the table below with E-values in parentheses. Fifteen hits
with negative E-values were retrieved from the HMM library12 Journal of Tropical Medicine
Table 3
Protein/domain with function P. falciparum P. knowlesi P. vivax P. yoelii
ATM (detection of DNA damage) PF13 0072 (−2)
PFD0690c (−2) PKH 051590 (−2) PVX 084530 (−5) —
p53 DBD (initiator of PCD) PFE1120w (−2)
PFE0325w (−1) —— —
MDM2/SWIB (negative regulation
of p53 activity) PF10 0167 (−1) PKH 060130 (−1) PVX 001730 (−2) PY00201 (−1)
CR6 (negative regulation of cell
cycle) MAL7P1.212 (−3) PKH 101090 (−1) — —
IAP (inhibitor of apoptosis) PFE0985w (−2) PKH 101280 (−3) PVX 080265 (−4) PY00703 (−1)
Peptidase C14 (execution of
apoptosis)
PF13 0289 (−22)
PF14 0160 (−1)
PF14 0363 (−1)
PKH 111640 (−25)
PKH 133100 (−2)
PKH 126800 (−1)
PVX 114725 (−22)
PVX 085640 (−2)
PVX 118575 (−1)
—
PY04718 (−2)
PY00663 (−1)
Abbreviations: ATM: ataxia telangiectasia mutated; CR: cell regulator; DBD: DNA-binding domain; IAP: inhibitor of apoptosis protein; MDM2: murine
double-minute 2; SWIB: swinged wings locus complex B; —: no orthologue detected.
for p53 DNA binding domains (DBD) and two of these
are included in the table. These encode proteins containing
predicted p53 DBD-like structural folds (antiparallel beta
sheets with greek key topology) according to PlasmoDB
v5.5 and positive FIRE scores. The FIRE algorithm predicts
the function of a domain based upon similar evolutionary
rates and produced scores of 0.71 and 0.68 for PFE1120w
and PFE0325, respectively (FIRE scores greater than 0.6 are
suggestive of similar functions).
C. MissingPiecesof the Puzzle
Apart from the problematic aspects regarding experimental
studiesonPCDinP.falciparum,whicharehighlightedinthis
paperand require furtherresearch, numerous additional and
challenging questions remain to be answered. A few of these
are outlined below.
(1) Which Life-Cycle Stage of P. falciparum Is Most Susceptible
to PCD? During its complex life cycle in two hosts and
diverse tissues, some stages may be more prone to PCD
than others to maximise parasite survival. Ookinetes in
the mosquito and rapidly growing intraerythrocytic tropho-
zoites and schizonts appear to be more susceptible to various
stimuli, in contrast to early ring stages. In particular, ring
stages are apparently not aﬀected by febrile temperatures,
and this has biological relevance, since periods of fever in the
host occur during this developmental stage.
Does the exposure of merozoites to host immune factors
render these extracellular forms of the parasite vulnerable to
PCD?
(2) What Makes Some Parasites within the Population More
Susceptible to PCD? The concept of PCD being adaptive in
unicellular organisms implies that only a subset of parasites
is destined to commit suicide to beneﬁt the remaining
members of the population, but how are they selected?
Natural infections of P. falciparum in endemic areas exhibit
a high degree of genetic diversity due to multiple infectious
mosquito bites, and since PCD should beneﬁt genetically
similar or identical kin, this may play a role in the selection
process. In areas of low transmission or in in vitro studies,
the parasites are clonal, implying that other selection criteria
are utilised. These are not yet known, but they may relate to
small diﬀerences in metabolic activity of individual parasites
or to diﬀerences in the microenvironment.
(3) What Are the Suicide Signals Inducing PCD? Several
clues are available from the pathogenesis of malaria, which
imply that the signals may potentially be provided by the
host, an individual parasite or a population of parasites.
In malaria patients, anaemia is a major and often life-
threatening consequence of infection, and to keep the host
alive, the parasite may elicit PCD in response to host factors
such as a decreased haemoglobin content or haematocrit and
altered blood viscosity. High parasitaemia in patients and in
in vitro cultures, or a large ookinete burden in the mosquito,
intuitively constitutes a parasite-derived PCD signal to
protect the host, and thereby ensure parasite survival.
Are the signals positive or negative? If trophozoites or
schizonts develop abnormally or are damaged by internal or
external factors, does this trigger removal of these defective
parasites? Alternatively, if a merozoite fails to invade an
erythrocyte, does the lack of a receptor-ligand interaction
trigger a default PCD pathway?
(4) Is There Communication between Parasites within a Popu-
lation? For parasite-derived signals to be eﬀective, a quorum
sensing mechanism must exist to allow parasites to be in
touch with each other, but the nature of this communication
system in P. falciparum is currently unknown. Furthermore,
since PCD involves killing a subset of parasites only, how do
parasites receiving the same message ensure that only some
of them react?
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